Bring Them On: 40 Orphan, Cancer Drugs Set For Priority Review In China

 
• By Brian Yang

New treatments for spinal muscular atrophy, glioblastoma, Gaucher's disease and others could be soon be hitting the China market following the awarding of priority reviews to a large list of novel therapies.

priority button
China Finalizes Priority Reviews For 40 Foreign Drugs • Source: Shutterstock

More from China

More from Asia